CXCan-Hua Xu

Can-Hua Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Can-Hua Xu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Fei-Xiang Lin

    Department of Spine Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People’s Hospital), Ganzhou, Jiangxi, China

    1 shared publication
  • Hou-Yun Gu

    Department of Spine Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People’s Hospital), Ganzhou, Jiangxi, China

    1 shared publication
  • Jun Xiong

    Nanchang University, Nanchang, China

    1 shared publication
  • Linbo Sun

    Nanchang University, Nanchang, China

    1 shared publication
  • Ning Liu

    Department of Spine Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People’s Hospital), Ganzhou, Jiangxi, China

    1 shared publication
  • Pingfan Mo

    Department of Spinal Surgery, Ganzhou Hospital–Nanfang Hospital, Southern Medical University (Ganzhou People’s Hospital), Ganzhou, China

    1 shared publication

Latest Publications

  • Melatonin improves mitochondrial function and redox balance in human cartilage endplate–derived stem cells

    by Pingfan Mo, Rongchun Chen, Linbo Sun, Yunsheng Chen, Jun Xiong, Yaohong Wu, Canhua Xu

    Mitochondrial oxidative stress is an important factor affecting the biological activity of stem cells under degenerative microenvironments. Cartilage endplate–derived stem cells (CESCs) are considered to participate in intervertebral disc homeostasis; however, their mitochondrial redox status under degeneration-related conditions remains incompletely characterized. In this study, human CESCs were isolated from patients with different degrees of intervertebral disc degeneration and used as an in vitro model to investigate mitochondrial oxidative stress. For intervention experiments, CESCs were treated with 100 µM melatonin for 24 h. Intracellular reactive oxygen species and mitochondrial superoxide were assessed using DCFH-DA and MitoSO™ Red, respectively. Mitochondrial membrane potential, ATP production, catalase and superoxide dismutase activities, and mitochondrial ultrastructure were evaluated. SIRT3 mRNA and protein expression were examined by quantitative real-time PCR and western blotting, and siRNA-mediated SIRT3 knockdown was used to explore its potential involvement in mitochondrial regulation. CESCs derived from advanced degeneration exhibited increased oxidative stress, decreased mitochondrial membrane potential, reduced ATP production, lower antioxidant enzyme activity, and greater mitochondrial ultrastructural damage. Melatonin treatment reduced intracellular ROS and mitochondrial superoxide accumulation and improved mitochondrial function. SIRT3 knockdown reduced SIRT3 mRNA and protein expression and partially attenuated the protective effects associated with melatonin. Melatonin increased SIRT3 mRNA expression, while SIRT3 protein expression was higher in the melatonin-treated group than in the SIRT3-siRNA group. These findings suggest that melatonin improves mitochondrial redox balance and mitochondrial function in human CESCs and that SIRT3 may participate in this regulatory process. The present study provides experimental evidence supporting a potential role for melatonin in modulating mitochondrial oxidative stress under degeneration-associated conditions.

  • Open Access

    Mechanism analysis and intervention strategies of the inflammatory microenvironment in traumatic spinal cord injury

    by Hou-Yun Gu, Fei-Xiang Lin, Ning Liu, Can-Hua Xu

    Traumatic spinal cord injury (tSCI) is a severe disabling central nervous system injury caused by external forces directly acting on the spinal cord. It can rapidly trigger the release of a large number of pro-inflammatory mediators after the injury, leading to significant neurological dysfunction and, in severe cases, paralysis. Currently, symptoms are mainly alleviated, and endogenous repair mechanisms are improved through drug intervention, surgery, stem cell transplantation, behavioral interventions, physical stimulation, and supportive therapies. However, these methods do not directly promote nerve regeneration and functional recovery. The inflammatory response after injury is an important pathological process leading to secondary damage and plays a crucial role in regulating the pathological progression of acute and chronic tSCI. However, prolonged inflammatory stimulation can further worsen the microenvironment at the injury site, leading to neurological function decline. Therefore, regulating the inflammatory microenvironment and restoring cytokine balance are expected to promote the recovery of neurological function after injury. This review summarizes the formation of the inflammatory microenvironment after tSCI, focusing on the recruitment and activation characteristics of major inflammation-related cells, and elaborates on the expression regulation, pathological effects, and impacts of key cytokines—including the interleukin family, TNF-α, and various chemokines—on neuronal survival and axonal regeneration. Additionally, we summarize multiple inflammatory signaling pathways closely related to secondary injury, such as NF-κB, JAK/STAT, and MAPK, emphasizing that these pathways are interconnected. For example, TNF-α and IL-1β can jointly activate NF-κB and MAPK to amplify the pro-inflammatory response and disrupt the blood-spinal cord barrier. Meanwhile, JAK-STAT3 amplifies inflammation while driving reactive proliferation of astrocytes and glial scar formation, thereby limiting later axonal regeneration. Based on this mutually amplifying inflammatory network, we also briefly summarize the exploratory applications of chemical antagonists, biologic agents, neuroprotective molecules, plant-derived active compounds, and hormonal interventions in regulating this microenvironment. This article aims to provide a reference for the analysis of inflammation-mediated pathological mechanisms after tSCI and the development of targeted anti-inflammatory treatment strategies.